Despite remarkable progress in medium‐term overall survival benefit in the adjuvant,
neoadjuvant and metastatic settings, with multiple recent targeted drug approvals, acquired …

Breast cancer is the most common malignancy among women, with the highest incidence
rate worldwide. Dysregulation of long noncoding RNA s during the preliminary stages of …

Background: Breast cancer is intrinsically heterogeneous and is commonly classified into
four main subtypes associated with distinct biological features and clinical outcomes …

Recent works have reported that long non-coding RNAs (lncRNAs) play critical roles in
tumorigenesis and prognosis of cancers, suggesting the potential utility of lncRNAs as …

Background Growing evidence has indicated that the long noncoding RNA H19 (lncRNA
H19), frequently deregulated in almost all tumor types tested, acted as a pivotal contributor …

Hepatocellular carcinoma (HCC) is the second leading cause of cancer‐related death over
the world. It is well studied that long noncoding RNA colon cancer–associated transcript‐1 …

DSCAM-AS1 is a cancer-related long noncoding RNA with higher expression levels in
Luminal A, B, and HER2-positive Breast Carcinoma (BC), where its expression is strongly …

Background Accumulating research reports have indicated that long non-coding RNAs
(lncRNAs) are abnormally expressed in many types of cancers. However, few lncRNA …

Molecular classification of acute myeloid leukemia (AML) aids prognostic stratification and
clinical management. Our aim in this study is to identify transcriptome‐wide mRNAs that are …

The expression abundance of transcripts in nondiseased breast tissue varies among
individuals. The association study of genotypes and imaging phenotypes may help us to …